Jan 8, 2026 04:22AM Abivax (ABVX) Reiterated at Market Outperform by Citizens: Has Cash Runway into 4Q27

Jan 8, 2026 04:16AM Abivax (ABVX) PT Raised to $150 at BTIG

Jan 8, 2026 03:58AM Leerink Partners on Abivax (ABVX): 'Key Clinical & Regulatory Catalysts on Track'

Dec 22, 2025 05:33AM Abivax soars on report of Eli Lilly meeting French officials over possible deal

Dec 17, 2025 04:05PM Abivax secures 22 abstracts on inflammatory bowel disease drug at ECCO 2026

Dec 16, 2025 04:08AM Abivax (ABVX) Cash Position Supports Obefazimod Development - Citizens

Nov 24, 2025 07:34AM Truist Securities Starts Abivax (ABVX) at Buy

Nov 4, 2025 04:56AM Citizens Reiterates Abivax (ABVX) at Market Outperform After Phase 3 ABTECT Study

Oct 13, 2025 05:29AM Barclays Starts Abivax (ABVX) at Overweight

Oct 10, 2025 06:08AM Abivax (ABVX) PT Raised to $150 at Guggenheim, named 'Best Idea'

Oct 7, 2025 04:06AM Abivax (ABVX) PT Raised to $115 at Leerink Partners

Oct 6, 2025 04:55AM Abivax presents ulcerative colitis drug data at gastroenterology meeting

Oct 6, 2025 04:03AM Citizens Reiterates Market Outperform Rating on Abivax (ABVX)

Sep 25, 2025 05:03AM Abivax (ABVX) PT Raised to $114 at Citizens JMP

Sep 23, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Rapport Therapeutics (RAPP)

Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Sep 15, 2025 12:52PM Guggenheim on Abivax (ABVX): 'We expect ABVX to get a late-breaker and/or a plenary session at the UEGW'

Jul 29, 2025 08:27AM Abivax (ABVX) PT Raised to $112 as Piper Sandler 'Continues to See Upside'

Jul 23, 2025 04:17PM Abivax launches $400 million public offering of American depositary shares

Jul 23, 2025 11:23AM Abivax (ABVX) PT Raised as Piper Sandler 'Remain Buyers'

Jul 23, 2025 08:29AM Morgan Stanley Upgrades Abivax (ABVX) to Overweight

Jul 23, 2025 07:54AM Abivax (ABVX) PT Raised to $74 at Leerink Partners

Jul 23, 2025 06:03AM Abivax (ABVX) PT Raised to $101 at Guggenheim

Jul 23, 2025 04:06AM Abivax (ABVX) PT Raised to $95 at Citizens JMP

Jul 18, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Jul 14, 2025 05:20AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Jul 2, 2025 09:42AM Piper Sandler Sees an 'Attractive Risk/Reward' on Abivax (ABVX) Shares

Apr 30, 2025 04:34AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Apr 22, 2025 04:00PM Abivax (ABVX) Appoints Dominik Höchli to its Board

Mar 25, 2025 09:56AM Guggenheim Reiterates Buy Rating on Abivax (ABVX), PT $50

Mar 25, 2025 04:36AM BTIG Reiterates Buy Rating on Abivax (ABVX)

Mar 20, 2025 03:21AM Morgan Stanley Assumes Abivax (ABVX) at Equalweight

Mar 18, 2025 04:04AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'

Dec 23, 2024 04:07PM Abivax (ABVX) Announces Board Changes

Dec 17, 2024 10:26AM Piper Sandler Reiterates Overweight Rating on Abivax (ABVX) Following New IBD Surveys

Dec 4, 2024 03:20AM JMP Securities Starts Abivax (ABVX) at Market Outperform

Nov 19, 2024 04:31PM Abivax (ABVX) Announces $150M ATM Program

Nov 13, 2024 04:03PM Abivax (ABVX) Appoints Mark Stenhouse as Board Observer

Oct 3, 2024 06:00AM Abivax (ABVX) Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod

Sep 30, 2024 06:12AM Guggenheim Reiterates Buy Rating on Abivax (ABVX)

Sep 26, 2024 12:11PM Piper Sandler Reiterates Overweight Rating on Abivax (ABVX)

Sep 26, 2024 08:21AM BTIG Reiterates Buy Rating on Abivax (ABVX)

Sep 25, 2024 04:01PM Abivax (ABVX) Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod

Sep 24, 2024 07:42AM Piper Sandler Reiterates Overweight Rating on Abbvie (ABBV)

Sep 10, 2024 07:45AM Piper Sandler Reiterates Overweight Rating on Abivax (ABVX)

Jul 16, 2024 05:53AM Piper Sandler Reiterates Overweight Rating on Abivax (ABVX)

Jul 15, 2024 04:00PM Abivax (ABVX) Provides Operational and Key Program Update